MAY 2015 ARTICLE LIST >>
PharmaTutor (May- 2015)
Print-ISSN: 2394 - 6679
e-ISSN: 2347 - 7881
(Volume 3, Issue 5)
Received On: 20/02/2015; Accepted On: 09/03/2015; Published On: 01/05/2015
AUTHORS: RH Shaikh1*, MJ Jamadar1, AD Patil1, AD Mali2, SM Tamboli1
1Department of Pharmaceutics,
Appasaheb Birnale college of Pharmacy, Sangali, Maharashtra, India.
2Department of Pharmaceutics,
Sahyadri College of Pharmacy, Methwade, Sangola, Solapur, Maharashtra, India
*rajshaikh71@gmail.com
ABSTRACT: The purpose of this investigation was to enhancement of solubility of cinnarizine by using solid dispersion technique solvent evaporation method using polymer PEG 6000 & develop combination ODT of cinnarizine with domperidone by using direct compression technique using crospovidone, croscarmellose sodium and sodium starch glycolateas a superdisintegrants. The preformulation study includes the compatability of drugs with the polymers by using FTIR,UV,TLC. The batches were evaluated for weight variation, hardness, friability, drug content, wetting time, IN In-vitro dispersion, in-vitro dissolution. The formulation F2 which contain 8% crospovidone and 10 % sodium starch glycolate showed best results and rapid in-vitro dissolution. The results revealed that the tablets containing superdisintegrants combination had a good dissolution profile. The drug content of all the batches was within the acceptable limits of the United States Pharmacopoeia with maximum drug being released at all timeintervals. The present study demonstrated potentials for rapidabsorption, improved bioavailability, effective therapy and patientcompliance. The results conclusively demonstrate successful enhancement of solubility, disintegration and dissolution of the formulated tablets.
How to cite this article: RH Shaikh, MJ Jamadar, AD Patil, AD Mali, SM Tamboli; Formulation and In-Vitro Evaluation of Antiemetic Orodispersible Combination Tablets of Domperidone and Cinnerizine by using various Superdisintegrants; PharmaTutor; 2015; 3(5); 49-59
[ABSTRACT WITH CITATION] [VIEW AS HTML]
REFERENCES:
1) Deshpande KB, Ganesh NS; Orodispersible tablets: an overview of formulation and technology; Int J Pharm Bio Sci; 2011; 2(1); 726–34.
2) Serajaddin A.; Solid dispersion technique; J. Pharma. Sci.; 1999; 88(10); 891-900.
3) Indian pharmacopoeia, 1996, Govt. of India.
4) European Pharmacopoeia. Council of Europe Strasbourg; 1999; 3rd ED: 229.
5) Joshi B, Patil V, Pokharkar V; Compatibility studies between carbamazepine and tablet excipients using thermal and non thermal methods; Drug Dev Ind Pharma; 2002; 28(6); 687-694.
6) ICH, Q2A Harmonized tripartite Guideline, validation of analysis procedures: text and methodology, International conference on harmonization, Geneva, March 1994.
7) ICH, Q2 (R1) harmonizer tripartite Guideline, validation of analytical procedure: text and methodology, international conference on Harmonization, Geneva, October 1994.
8) Gavini E, Sanna V, Rassu G, Testa C, Hegge A; Nasal administration of carbamazepine using chitosan microsphere In vitro/ In vivo studies; Int.J.Pharma; 2006; 307(1); 9-15.
9) Higuchi T, Connors K; Phase solubility technique; Adv .Anal. Chemc. Instr;.1965; 4; 117-212.
10) Katara O, Ahuja N, Sing B; Studies on dissolution enhancement and mathematical modeling of drug release of poorly water-soluble drug using water soluble carrier; Eur. J Pharma. Biopharma; 2007; 65(1); 26-28.
11) Tayade P, Modi A; Enhancement of Dissolution profile by using solid dispersion technique; AAPS PharmaSci Tech. 2006; 7(3); 68.
12) Ferioli V, Rustichelli C, Gamberini G.; Solid state study of polymorphic drugs: Carbamazepine; J Pharma and Bio Anal; 2000; 23(1); 41-54.
13) Bikiaris D, Karavas E; Investigation of release mechanism of a sparingly water soluble drug from solid dispersion in hydrophilic carriers based on the physical state of drug; Eur. J. Pharma Biophama; 2007; 66(3); 334-347.
14) Schmidt PC, Schiermeier S; Fat dispersion ibuprofen tablets; Eur. J. Pharmasci; 2002; 15(3); 295-305.
15) Vijayalakshmi P, Jha SK, Divakar g. Formulation and Evaluation of melt-in-mouth tablets of haloperidol; Asian journal of pharmaceutics; 2009; 2(4); 255-260
16) Subramanyam C.; Text book of physical pharmaceutics; vallabhPrakashan; 22nd ed; 2001.
17) Mehta R.; Pharmaceutics-I; VallabhPrakashan; 2nd edition; 1997.
18) Ramesh A, Shirwaikar A; Fast disintegration tablets of atenolol by dry granulation method; Indian J Pharma Sci.; 2004; 66(4); 422-426.
19) Badhan A, Kuchekar B, Mahajan H; Mouth dissolving tablets of salbutamol sulphate: A novel drug delivary system. Indian drug; 2004; 41(10); 592-595.
20) Manuel J, Costa P; Loba S; Modeling and comparison of dissolution profiles; Eur. J. Sci; 2001; 13(2); 123-33.
21) who.int/medicines/areas/quality_safety/quality_assurance/RAJ2006WHOStability.pdf
.png)
